Department of Urology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Urol Oncol. 2019 Aug;37(8):530.e1-530.e8. doi: 10.1016/j.urolonc.2019.03.002. Epub 2019 Mar 29.
Histological grade is an important prognostic factor in patients with non-muscle-invasive bladder cancer (NMIBC). However, interobserver variability is high. Previous studies have suggested that quantification of histological features is useful to objectify grading. We evaluated whether quantification of the mean nuclear area of the 10 largest nuclei (MNA-10), degree of aneuploidy (DNA index or DI) and mitotic activity index (MAI) are of diagnostic value for NMIBC grade. Additionally, prognostic value of the 3 measures was assessed.
A consensus grade was determined by 3 uropathologists in 310 NMIBC tissues according to the World Health Organization (WHO) 1973 and the WHO2004. Logistic regression with forward selection was used to determine the optimal combination of measures (MNA-10, DI, and MAI) to diagnose grade 3 (G3) or high-grade (HG) NMIBC (WHO1973 and WHO2004, respectively).
In 310 tumors of 215 patients at least 1 of the measures (MNA-10, DI, or MAI) had been determined. The combination of MNA-10 and MAI was selected as the most diagnostic combination and resulted in a sensitivity of 94% (95% confidence interval [CI]: 87-100) at a specificity of 72% (95% CI: 66-78) for G3 tumors. For the diagnosis of HG tumors sensitivity was 92% (95% CI: 86-97) at a specificity of 76% (95% CI: 70-93).
Determination of MNA-10 and MAI is promising for diagnosing G3 and HG bladder tumors. These findings warrant further studies on the diagnostic and prognostic value of proliferative and quantitative features in bladder cancer patients.
组织学分级是非肌肉浸润性膀胱癌(NMIBC)患者的一个重要预后因素。然而,观察者间的变异性很大。之前的研究表明,对组织学特征进行定量分析有助于对分级进行客观化。我们评估了 10 个最大核的平均核面积(MNA-10)、非整倍体程度(DNA 指数或 DI)和有丝分裂活动指数(MAI)的定量是否对 NMIBC 分级具有诊断价值。此外,还评估了这 3 项指标的预后价值。
根据世界卫生组织(WHO)1973 年和 2004 年标准,3 位泌尿科医生对 310 例 NMIBC 组织中的共识分级进行了确定。使用向前选择的逻辑回归来确定诊断 3 级(G3)或高级别(HG)NMIBC(WHO1973 年和 WHO2004 年)的最佳指标组合(MNA-10、DI 和 MAI)。
在 215 名患者的 310 个肿瘤中,至少有 1 个指标(MNA-10、DI 或 MAI)已经确定。MNA-10 和 MAI 的组合被选为最具诊断价值的组合,其对 G3 肿瘤的敏感性为 94%(95%置信区间[CI]:87-100),特异性为 72%(95% CI:66-78)。对于 HG 肿瘤的诊断,敏感性为 92%(95% CI:86-97),特异性为 76%(95% CI:70-93)。
MNA-10 和 MAI 的测定对诊断 G3 和 HG 膀胱癌有一定的前景。这些发现进一步证实了在膀胱癌患者中,增殖和定量特征的诊断和预后价值值得进一步研究。